Explore
Premium
Sign Up
Log In
Current Perspectives on the Use of Digoxin - Mohammad Shenasa
↳ This is a section part of Moment:
ISCP 2017 - Sudden Cardiac Death and Syncope - Joint Session ISCP and ESC WG of Pharmacotherapy
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$19.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Preview
Summary
Current Perspectives on the Use of Digoxin - Presented by Mohammad Shenasa at ISCP 2017.
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$19.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Target Audience
Cardiologists, interventional Cardiologists
Interventional Fellows
Interventional Radiologists
Vascular Surgeons
Emergency Physicians
Learning Objectives
Other Components in this Moment
Overview
Welcome and Opening Ceremony of the ISCP Congress 2017 - Antoni Martínez-Rubio
Syncope: Differential Diagnoses and Signs of High Risk - Ángel Moya
Pharmacotherapy in Neurocardiogenic Syncope: New Options - Carlos Morillo
Primary and Secondary Prevention of Sudden Cardiac Death in Ischemic Heart Disease and Myocardiopathies: Do Drugs Have any Role? - Juergen Kuschyck
Primary and Secondary Prevention of Sudden Cardiac Death in Channelopathies: Role of Drugs and Devices - Josep Brugada
The interplay Between Atrial Fibrillation and Sudden Cardiac Death - Martin Borggrefe
Current Perspectives on the Use of Digoxin - Mohammad Shenasa
Discussion of ISCP 2017 - Sudden Cardiac Death and Syncope - Joint Session ISCP and ESC WG of Pharmacotherapy
Loading Simple Education